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1.  Executive Summary 
Although  a  hypodermic  needle  inserted  through  the  stratum  corneum,  the  uppermost 
layer of skin, and into the tissue can deliver drugs effectively, it can lead to infection and 
be  very  painful.  Transdermal  drug  delivery  mediated  by  various  microneedle 
technologies is a less painful method of drug delivery that also limits infection. Also, as 
with  hypodermic  needles,  the  microneedles  successfully  bypass  the  thick  stratum 
corneum which is a limiting factor in transdermal drug delivery. One application of this 
technology is the delivery of pain medication to the skin of burn victims. A drug patch 
containing  ibuprofen  can  be  placed  over  an  array  of  microneedles  inserted  into  the 
patient’s damaged skin. In this study, the drug concentration in the burn victim’s dermis 
over  time  was  modeled  using  COMSOL  software.  The  effects  of  initial  drug 
concentration in the patch and spacing between needles of the microarray were examined 
to develop an optimized model of drug delivery through second degree burns. Initially, a 
two dimensional model of a single microneedle inserted into the dermis was used to test 
assumptions made about drug diffusion through burnt skin. A three dimensional model 
was  then  constructed  to  examine  the  effects  of  microneedle  spacing  on  the  drug 
concentration profile. To determine the optimal setup, the average drug concentration in 
the burnt skin was measured while varying initial ibuprofen concentration in the patch 
and microneedle spacing. The results showed that the patch should contain a 0.4 mol/m
3 
concentration  for  a  two  hour  application  with  100  micrometer  spacing.  The  optimal 
microneedle  spacing  was  found  to  be  a  nearly  linear  function  of  the  patch  drug 
concentration the manufacturer aims to use. 
 
Key words: microneedles, diffusion, second degree burns, ibuprofen   
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2.  Introduction 
Hypodermic  needles  are  currently  the  standard  method  of  delivering  medication 
transdermally.  However, because the use of hypodermic needles can be painful and introduce 
infection, alternate modes of drug delivery have been developed. Drug patches are a painless 
alternative to hypodermic needles, but their drug delivery can be significantly limited by the 
stratum corneum, the upper layer of the skin.  Microneedle arrays can be used in conjunction 
with drug patches to enhance drug delivery while also limiting a patient’s risk of infection and 
discomfort. One application of this technology is the delivery of pain medication, like ibuprofen, 
to  the  skin  of  burn  victims.  To  administer  the  ibuprofen  to  the  burnt  skin,  an  array  of 
microneedles is inserted into the patient’s skin and a drug patch is placed on top (Figure 1). The 
ibuprofen diffuses through the hollow microneedles and into the skin, which allows the drug to 
reach the burnt skin more quickly than with a drug patch alone. In order for ibuprofen to be an 
effective analgesic, its concentration in the dermis must be at least 30 mg/kg of body mass, 
which is the recommended dose for an adult. The concentration in the dermis, however, must 
remain under 100 mg/kg of body mass, which is the concentration at which ibuprofen becomes 
harmful [1].  Therefore, the initial ibuprofen   concentration in the drug patch and the spacing of 
the microneedles in the array must be chosen to maintain an effective but harmless concentration 
of drug in the skin. This report presents a computer model of ibuprofen diffusion through a 
microneedle array that can be used to determine optimized microneedle spacing and initial drug 
patch concentration for delivery of ibuprofen to the dermis of a burn victim. 
3.  Design Objectives 
We planned to use COMSOL to model the use of microneedles and drug patches for the 
treatment of second degree burns. The main objective of our model was to allow us to optimize 
the microneedle spacing in an array and the ibuprofen concentration of the patch. The following 
two dimensional (Figure 1) and three dimensional (Figure 2) models were used to achieve these 
goals. BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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Figure 1- Schematic of two dimensional geometry for a single microneedle and the affected burnt skin. 
 
Our  initial  goal  was  to  model  a  single  needle  in  two  dimensions  (Figure  1).  We 
determined from existing literature [1] the ideal concentration of ibuprofen (30 mg of drug/kg of 
body  mass)  for  localized  use  in  the  dermis.  Then,  we  developed  a  transient  model  of  the 
ibuprofen  concentration  at  the  burn  area.  This  two  dimensional  model  was  used  to  quickly 
evaluate our geometry and validate our assumptions about the behavior of a single microneedle. 
It also allowed us to perform a sensitivity analysis and refine our parameters before moving 
forward to the three dimensional case. 
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Figure 2- Three dimensional model of four microneedles in a square array implanted in the region of burnt skin for 
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The objective of the three dimensional case was to account for the interaction of multiple 
needles in an array. The 2D case was the basis for the properties and assumptions used in the 3D 
case. With the three dimensional model, we varied the spacing between the microneedles and 
initial concentrations of ibuprofen in the drug patch in order to determine a scenario resulting in 
optimal ibuprofen concentration in the dermis.  
4.  Two Dimensional Design 
Assumptions of 2D Design 
  Our 2D model (Fig.1) consisted of microneedles arranged in circular arrays as shown in 
Figure 3. 
 
Figure 3- A circular microneedle array [2]. 
 
Due to the circular symmetry of this array, our 2D model assumed a flux of zero at each center 
point  between  two  microneedles;  we  also  assumed  zero  flux  at  the  radial  center  of  each 
microneedle. These assumptions are also present in our schematic (Fig. 1). We assumed drug 
transport by simple diffusion. Because microneedles are often flushed with water before a patch 
is applied, we used the diffusivity of ibuprofen in water in our set-up to model the movement of 
drug through the microneedle. In addition, we assumed that the blood acts as a concentration 
sink and provides a driving force for this diffusion. There is a silicon layer between the patch and 
the skin that serves to keep the microneedles in place and also prevents diffusion of ibuprofen 
from the patch into the skin. Therefore, we assumed no drug diffusion from the patch into the BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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skin between microneedles. As a final assumption, we used uniform physical properties of the 
burnt skin. 
 
Results from 2D Analysis 
The two-dimensional model was solved completely, independent of the three dimensional 
case.  The  mesh  convergence,  sensitivity  analysis  and  further  details  of  the  2D  solution  are 
available  in  the  appendix.  Here,  however,  our  discussion  will  focus  on  those  results  which 
influenced the following 3D design. Our two dimensional model showed that there was no drug 
diffusion  through  the  healthy  dermis  over  the  range  of  initial  drug  concentrations  used.  In 
addition, our 2D sensitivity analysis (Figure 19) showed that our model was not sensitive to the 
diffusivity  of  Ibuprofen  through  the  healthy  dermis,  which  allowed  us  to  get  rid  of  this 
subdomain in the 3D model and move the concentration sink to the bottom of the burnt dermis. 
In order to determine what regions of our 3D model needed the finest mesh, we looked at 
a plot of the Ibuprofen concentration generated at an early time of 100s (Fig. 4).  BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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Figure 4 - Ibuprofen distribution in the needle tip and burnt skin at 100s.  
This graph shows that the region of greatest change was in the burnt dermis located near the 
microneedles. Therefore, we made a finer mesh in this region of the burnt dermis for the 3D 
model.  
Another finding in the 2D model which allowed simplifications to be made to 3D design 
was showing that the Ibuprofen concentration profile over time had little variation at different 
points within the needle (Figure 5). BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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Figure 5- Comparison of Ibuprofen concentration over time at 2 points in the microneedle. The represents our justification for 
replacing the physical patch and needle with a boundary condition in the 3D model. 
The data in Figure 5 shows that diffusion from the patch through the microneedle to its tip is not 
influencing the concentration profile at the interface between the microneedle tip and the target 
skin. Because the patch and needle properties did not alter the concentration profile, it was 
unnecessary to build, mesh, and compute these parts of the geometry in 3D. Instead, the 2D 
model was used to obtain the concentration profile at the needle tip (as seen in Fig. 5) and apply 
this function as a boundary condition at the needle tip in the 3D model. 
5.  Three Dimensional Design 
Geometry and Governing Equations 
The  governing  equation  of  our  problem  was  the  mass  transfer  equation  in  Cartesian 
coordinates. There was no reaction or convection, so only the transient and diffusion terms were 
included. As follows: 
 
The equation was applied to a three dimensional model of an array subset of four needles (Fig. 2), 
as  previously  discussed.  Modeling  of  an  entire  array  could  be  estimated  by  tiling  these 
components; thus it was not necessary to analyze an array of the size that would be manufactured. 
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We also took full advantage of the symmetry of our situation. The dashed lines in Figure 
2 show the four existing axes of symmetry. Because the model can be tiled to achieve a larger 
array, only a quarter of each of the four needles needed to be meshed and evaluated. These 
observations greatly reduced our computation time as did some astute observations. 
As mentioned in discussion of the 2D results, one of the more crucial changes from our 
2D model to the 3D model was to replace the physical representation of the patch and needle 
center with a needle-tip boundary condition. This varying boundary condition was found from 
the 2D model which was run with all the appropriate constants and the drug concentration at the 
needle  tip  was  recorded  as  a  function  of  time.  The  main  reason  for  implementing  a  three 
dimensional  model  was  to  perform  spacing  studies.  Therefore,  it  was  crucial  that  all  data 
collected from the 2D setup for use in the 3D model reflected the correct distance between 
needles. The concentration at the needle tip as a function of time was found in 2D models of a 
50um needle-to-needle spacing as well as its 30% larger counterpart.  These profiles are shown 
in Figure 6.  BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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Figure 6- Shows the concentration factor vs. time profile for two different spacing, the 50 and the 65um.  
As one may notice, the two spacings produce a nearly identical concentration factor profile that 
varies only by roughly 1%. Thus, it is not necessary to build a 2D corresponding to every 3D 
spacing  desired  to  acquire  a  concentration  boundary  condition.  The  Ibuprofen  concentration 
profile at the needle tip of a single 2D spacing was applied to all 3D studies. This approach to the 
3D needle tip concentration boundary condition greatly simplified the amount of input work 
required to run the necessary simulations. 
  The other parameter we were varying was the initial drug concentration in the patch. It 
was, therefore, important to also demonstrate how changes in the patch’s drug concentration at a 
single spacing altered the concentration profile at the needle tip. A plot of concentration factor 
versus time for different  patch concentrations  shows the linearly  relationship between initial 
concentration in the patch and concentration profile at the needle tip.  
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Figure 7 – This plot shows the concentration factor vs. time for different patch concentrations for the 50um needle 
spacing. 
Looking at the Figure 7 it becomes apparent that the value of the concentration factor curve is 
directly related and proportional to the initial patch concentration. In the example given in Figure 
7 it is apparent that the 1 mol/m
3 is twice as large in magnitude as the 0.5 mol/m
3 curve.   
Mesh Plot 
Our mesh used free mesh triangular elements, and a maximum element size was specified 
for each subdomain. The subdomains with the most drug diffusion were most finely meshed.  
The subdomains and their corresponding maximum element sizes are tabulated below in Table 1.  
Table 1: 
Subdomain  Maximum Element Size (m) 
Top portion of burnt skin  2 x 10
-5 
Middle portion of burnt skin  2 x 10
-5 
Bottom portion of burnt skin  5 x 10
-5 
Impermeable needle wall  5 x 10
-3 
Needle tip  2 x 10
-3 
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The mesh in the area near the needle tips is also shown in Figure 8. As Table 1 indicates, the 
mesh  varies  from  very  fine  in  areas  of  great  interest,  namely  the  burnt  skin  nearest  the 
microneedles, to fine in the lower burnt region. 
 
Figure 8 - The mesh of a 3D section of burnt skin varying in number of mesh elements relative to the microneedle 
proximity. 
 
Results of 3D Modeling 
The resulting contour plot of the drug distribution after 2 hours using the three dimensional 
model is shown in Figure 9. BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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Figure 9 - Results after two hours of low concentration drug diffusion into burnt skin using 3D model. 
The  results  show  a  decreasing  concentration  as  one  moves  further  from  the  needle  tips  as 
expected. 
6.  Sensitivity Analysis 
Sensitivity analysis was performed to gauge the effect of error in the chosen parameter 
values on the optimization and its final solution. The sensitivity analysis for both models was 
conducted at a time of two hours and measured through changes in the average concentration of 
the  drug  in  the  burnt  skin  segment.  The  variables  that  were  analyzed  included  initial  drug 
concentration, diffusivity  of  drug in  the needle,  diffusivity of drug in  the burnt dermis, and 
diffusivity of drug in the healthy dermis. The 2D model also examined sensitivity of the average 
concentration to the diffusion coefficient in the patch, a factor that was eliminated in the 3D 
model. Furthermore the 3D model lacks the healthy skin section present in the 2D model. All 
testing was done at the initial drug concentration of 0.2 mol/m
3. The results of the sensitivity BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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analysis in the two dimensional case are available in Figure 19. The three dimensional model 
responds to changes as shown in Figure 10. 
 
 
Figure 10 - Graph of sensitivity analysis of the 3D model showing the amount of change in the model outcome 
following a 10% increase or decrease in a single parameter value. 
The results of the 3D sensitivity analysis are, for the most part, in near correspondence with 
those of the 2D sensitivity analysis. This assures that the assumptions taken to produce the 2D 
model  were  reasonable  and  had  minimal  effects  on  the  accuracy  of  the  solution.  The  drug 
concentration at the needle-patch boundary has the greatest effect on average burnt skin drug 
concentration. Variability in this factor on the magnitude of 10% caused a change of roughly 9-
10% in both the 2D and 3D model. 
   The diffusivity of drug through the needle as well as the patch showed a moderate effect 
on the average burnt skin drug concentration in the 2D model and were evaluated at around 4 
and 5% respectively. The 3D model lacked both a needle as well as a patch component. 
  Burned skin diffusivity changes showed a modest change of roughly 5% in relation to 10% 
shifts in diffusivity for the 3D model. This is of concern since this is not in agreement with the 
9.9% 5.2%
Initial Drug Patch 
Concentration
Drug Diffusivity in 
Burned Skin
10.9%
4.1%
0.0E+00
1.0E-03
2.0E-03
3.0E-03
4.0E-03
5.0E-03
6.0E-03
7.0E-03
8.0E-03
9.0E-03
D
r
u
g
 
C
o
n
c
e
t
r
a
t
i
o
n
 
i
n
 
B
u
r
n
e
d
 
S
k
i
n
 
[
m
o
l
/
m
^
3
]
10% down
normal
10% up
3D Sensitivity Analysis BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
15 
 
2D model where this variable effect stood at a mere 0.5%. We believe that this is due to the fact 
that the 3D model does not have a patch or an actual needle space. In the 2D model the patch and 
the needle is given an initial concentration and a unique diffusivity. This creates an environment 
where both of these model spaces have an effect on the actual concentration felt by the burnt 
dermis. In the 3D model, however, the modulation of the concentration is completely placed on 
the burnt dermis as the patch was completely removed while the needle was reduced to a simple 
slice for computational feasibility. 
   The effect of diffusivity of the healthy skin variability showed a very small effect on the 
final solution. This effect was calculated to be near 0%, further validating the removal of this 
component from the 3D model.  
7.  Optimization of Design 
To select the optimal design, we determined the relationship between average ibuprofen   
concentration in the burnt skin after 2 hours, simulated initial drug concentration in the patch, as 
well as needle spacing. Optimization was done using the 3D model for a more realistic answer 
that encompasses needle-needle interaction and diagonal spacing not handled by the 2D model. 
The results, obtained with COMSOL, are shown in Figure 11, which shows the average drug 
concentration in the burnt skin section as a function of both needle spacing and initial patch 
concentration.  BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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Figure 11 – Plot showing the interaction of initial Ibuprofen concentration in the patch and needle spacing, and the 
resulting average Ibuprofen concentration in the burnt skin. 
As one may notice the model exhibits an almost linear response to both needle spacing and initial 
patch concentration. This makes sense since all of the components to the diffusivity equation are 
linear and varying needle spacing influences the amount of the drug sink/source in a completely 
linear matter.  
A model of this sort provides the design team with all sorts of combinations of spacing 
and initial concentration that would effectively cause the desired average concentration in the 
burnt skin. The target concentration of ibuprofen in the burnt skin after 2 hours was an average 
of 0.20 mol/m
3, while the maximum recommended dosage was roughly 0.66 mol/m
3. This close 
difference between the two boundaries forced us to seek an average  rather than a minimum 
concentration of 0.20 mol/m
3 because that latter case resulted in greatly too high values at the 
patch-skin  boundary  that  experiences  the  greatest  amount  of  flux.  A  sample  profile  can  be 
observed in the Figure 21, which shows the concentration difference as a factor of roughly 12.5 
of  concentration  at  the  patch/burnt  skin  boundary  versus  burnt/healthy  skin  boundary. 
Accordingly for this specific model setup establishing an minimum concentration of 0.20 mol/m
3 BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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would  result  in  a  maximum  concentration  of  2.5  mol/m
3,  grossly  above  the  maximum 
recommended dosage.  
  To measure the effect of spacing on the drug transport we evaluated the 3D model at a 
variety  of  needle  spacing.  To  quantify  the  effect  of  spacing  we  obtained  a  vertical  drug 
concentration profile across the burnt skin section and calculated its standard deviation. The 
standard deviation is a measure of the compactness of the values across the distribution. Thus by 
minimizing  the  standard  deviation  across  this  burnt  skin  distribution  we  were  maximizing 
uniformity across the section. This would allow the designers to place higher concentrations in 
the patch and thus achieve higher minimum concentrations while staying below the maximum 
recommended  concentration.  The  results  of  this  optimization  can  be  observed  in  Figure  12, 
below. 
 
Figure 12 - Shows the relationship between the needle spacing and vertical concentration variability in the burnt 
skin  section  of  the  3D  model.  All  values  shown  are  those  of  optimal  setups  yielding  average  0.20  mol/m
3 
concentrations for each spacing.  
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  As one can clearly see there is a very strong linear relationship between needle spacing 
and vertical variability in the burnt skin section. Using an objective function that maximizes 
uniformity across the model, we would end up with a theoretical spacing of 0, which is the 
physically common sense solution that we did not see at the forefront of objective design for this 
project. The real and practical answer is that the optimal spacing will depend on application and 
the desired results. Increased needle spacing ensures less discomfort to the end-user, but has the 
disadvantage of less uniform concentration diffusion. It is up to the designer and the medical 
objective in question to figure out proper tolerances and spacing needs.  
  We can, however, comment on the ideal patch drug concentration versus needle spacing 
relationship. Figure 13 shows the relationship that we discovered during our simulation.  
 
Figure 13- Shows the optimal patch concentration of ibuprofen as a function of needle spacing.  
As one may observe the optimal concentration of the drug in the patch varies very much linearly 
with needle spacing. This is an intuitively correct solution since by adding inter-needle distance 
we are adding linearly as much drug sink as source. The only potential limiting factor in this 
observation is that the needle size remains the same and now has to transport a larger quantity of 
drug. This, however, is a non-issue since the needle diffusivity is much larger than the either 
patch or burnt skin diffusivity. Thus it flows from this observation that needle flow limitations 
are  not  the  bottleneck  and  the  graph  in  Figure  13  fully  agrees  with  the  common  sense 
interpretation of the situation.   
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8.  Accuracy Check 
Research through current publications does not indicate that values have been found for 
ibuprofen concentration in skin using a microneedle array. However, transdermal drug delivery 
applications have been researched in other ways that may be compared to our application. 
The model that we have chosen to verify our setup is a published study regarding the 
delivery of BSA to rat skin via a microneedle array of spacing 200um, initial patch concentration 
of 6250 ug/cm
2, and diffusivity of 315.8 ug/cm
2/hour [3]. Using this information we were able to 
modify our model in terms of design and parameters while keeping the same fundamental setup 
shared  with  our  own  model.  While  the  experimental  and  modeling  representations  of  drug 
depletion from a patch result in some difference after long times, we are concerned mainly with 
the 4 hour period in which Ibuprofen is typically administered. Figure 14 shows our results of 
this time period which follow the same trend in the experiment over this timeframe. 
 
Figure 14 – Plot for accuracy check which shows the same trend of drug present in burnt tissue versus time as the 
experimental setup. 
It is also interesting to note that both the 2D model and the 3D model showed nearly identical 
concentrations under identical model setup. This trend can be observed in the sensitivity analysis 
portion and mainly Figure 10 and 19. 
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9.  Conclusion 
Microneedles  can  be  effectively  used  to  increase  drug  transport  from  a  drug  patch 
through  the  epidermis  without  causing  infection  or  discomfort  in  the  patient.  A  three-
dimensional model of ibuprofen   through burnt skin was created to examine the effects of initial 
drug  patch  concentration  and  microneedle  spacing  on  the  drug  concentration  profile  in  the 
dermis.  The results of this optimization can be viewed in Figures 12 and 13. This model and 
these results can be used for design of ibuprofen microneedle systems as well as other drug 
systems since the fundamental physics remain the same. Needle spacing remains a factor that has 
to be determined in situ and will vary for different applications.  
10.   Design Recommendations 
    Our model of drug diffusion through burnt skin could be improved to make a more 
realistic  three-dimensional  model  of  transdermal  drug  delivery  to  burn  victims.  One  of  our 
biggest challenges was finding the input parameters needed for this model. For some parameters, 
such  as  the  diffusivity  of  ibuprofen  through  burnt  skin,  we  estimated  the  values  based  on 
available data for similarly sized and structured molecules. Because, according to the sensitivity 
analysis, the model is most sensitive to the diffusivity of ibuprofen through the burnt skin, it 
would be very important to have an accurate value for this parameter. Therefore, future models 
should strive to find more accurate input parameters.  
  Our model examines simple drug diffusion through the burnt dermis without the use of a 
pharmacokinetic model for the behavior of the drug in the skin. However, our setup could be 
made more realistic by including a pharmacokinetic model such as the one seen in Al-Qallaf’s 
model  of  transdermal  drug  delivery:   [4].  In  this  model  Ke  is  the 
elimination  rate  constant  from  the  blood  compartment,  dQ/st  is  the  penetration  rate  of  drug 
through the skin, Sa is the surface area of the microneedle array, Vb is the volume of distribution 
in  the  blood,  and  Cb  is  the  drug  concentration  in  the  blood  [4].  While  we  were  unable  to 
implement this model because we could not find the necessary pharmacokinetic constants for 
ibuprofen,  we  would  recommend  that  future  models  consider  including  pharmacokinetic 
behavior of the drug in the skin.   BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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  Finally,  the  model  could  be  improved  by  incorporating  drug  diffusion  into  the 
bloodstream. When performing our accuracy check, it was difficult to find research papers that 
discussed the desired concentration of ibuprofen in the dermis of a patient.  Instead, research 
papers  discuss  drug  concentration  in  the  bloodstream.  Therefore,  for  the  purposes  of  data 
validation and verifying accuracy, it would be an improvement on our model to include the 
bloodstream in the geometry.  
11.   Realistic Constraints 
Microneedle  arrays  can  be  successfully  used  as  a  less  painful  alternative  to  hypodermic 
needles in many applications. They are also able to enhance transdermal drug delivery from a 
drug patch. However, there are some realistic constraints that could prevent microneedle arrays 
from becoming the standard tool of transdermal drug delivery. Because this method of drug 
delivery involves both a drug patch and a microneedle array, it may be more work to produce 
than hypodermic needles. Additionally, because microneedles are a relatively new technology 
and  are  more  structurally  complicated  than  hypodermic  needles,  it  likely  costs  more  to 
manufacture these arrays. Therefore, it could be difficult to convince healthcare providers to use 
microneedle arrays and not hypodermic needles. Indeed, healthcare providers and patients would 
have  to  be  taught  the  potential  advantages  of  microneedle  arrays  (such  as  a  lower  risk  of 
infection and less discomfort for the patient) before they could replace hypodermic needles. 
Additionally, there would still be applications where hypodermic needles would be preferable, 
such as IVs and blood drawing.   
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12.   Appendix A: Mathematical Statement of Problem 
Governing Equation: Mass transfer equation in cylindrical coordinates 
 
Boundary Equations: 
 
 
Initial Conditions: 
Layer  Initial Concentration 
    Microneedle Tip  54370-163110 mol/m
3 
Burnt Dermis  0 mol/m
3  
 
The initial microneedle tip concentration was varied between 54370 mol/m
3 and 163110 mol/m
3 
during the optimization process.   
   
1.6 mm Burnt Skin 
80 µm-160µm 
Needle Spacing 
Radius = 5µm Hole 
Radius = 25µm Impermeable                
Needle Membrane 
Axes of Symmetry 
Conc. = 0 
0.2 mm 
Needle Length 
 Figure 15- Three dimensional model of four microneedles in a square array implanted in the region 
of burnt skin for which these needles provide drug. 
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13.   Appendix B: 2D Schematic and Results 
 
Figure 16- Schematic of two dimensional geometry for a single mirconeedle and the burnt skin it affects. 
 
Governing Equation:  Mass transfer equation in cylindrical coordinates 
 
Initial Conditions: 
Layer  Concentration 
Drug Patch            54370 – 163110 mol/m
3 
Microneedle Tip  0 mol/m
3 
Burnt Dermis  0 mol/m
3  
   
Inner diameter of the tip of the microneedle:  
10 microns 
Outer diameter of the tip of the microneedle: 
50 microns 
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Results of 2D Design 
 
Figure 17- Initial conditions for 2D case. Contour plot for 2D schematic at time = 0 seconds and Co = 14375 mol/m3. BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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Figure 18- Contour plot for 2D schematic at time = 7200 seconds and Co = 14375 mol/m3. 
 
2D Sensitivity Analysis BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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Figure 19- Graph of sensitivity analysis of the 2D model showing the amount of change in the model outcome 
following a 10% increase or decrease in a single parameter value. 
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14.   Appendix C: Mesh convergence 
2D Mesh 
 
Figure 20- Mesh distribution for 2D model. Mesh is rectangular and specified by edge. 
 
For the 2D model, a mesh convergence analysis was performed and resulted in the following 
mesh at the converged point. 
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Figure 21 - Average ibuprofen   concentration in burnt skin vs. # of mesh elements. BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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 Figure 22- Sample vertical concentration profile for drug diffusion in the 3D model. Setup shown is for the 
optimal concentration of the 80um needle spacing and at the center line of the burnt skin area. Average 
concentration shown is 0.20 mol/m
3.  
 
The average drug concentration in the burnt skin starts to converge around 22000 mesh elements 
at 1806 mol/m
3. A large number of mesh elements is required for convergence. One reason for 
this large value is that compared to the depth of the skin, the length and width of the needle are 
relatively small.  Also, because the drug is expected to diffuse, the concentration in the needle tip 
is quite large. Since a large concentration of drug diffuses out of a small area, the surrounding 
area is very dynamic and requires a fine mesh. 
3D Model Mesh 
The 3D model used the maximum amount of elements allowed by the computer’s memory to 
solve the schematic created. Therefore, the mesh could not have been further refined. BEE 4530            Use of Microneedle Arrays for the Treatment of Second Degree Burns   Cutter, Ince, Matlock, Rutkowski 
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15. Appendix D: Physical Constants 
Table 2: Physical Constants 
Constant  Value  Source 
Diffusivity of patch reservoir  1 E -11 m
2/s  Datta, A. and Rakesh, V [4] 
Diffusivity of ibuprofen   in water  7.3E-10 m
2/s  Feng, H. and Bellantone, R.  [3] 
Diffusivity  of  ibuprofen    in  burnt 
epidermis 
3.056E-11 m
2/s  Sharif, B. et al [5] 
Diffusivity of ibuprofen   in healthy 
dermis 
5.34638889E-15 m
2/s  Herkenne, C. et al. [6] 
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